Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Explore various ways to increase sales in your small business. These strategies can help you boost profits and enhance revenue.
21,151 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
Optimum (OPTU) is reshaping its strategy in 2026. This original analysis dives into the Q1 results, margins, and capi...
Nu Holdings, a fintech once tied to Warren Buffett, has fallen about 30% from its highs and now trades around $13, pr...
Marvell Technology recently reached a new high, prompting questions about its staying power. This guide breaks down t...
A seasoned investor reveals a stubborn bet on Microsoft, arguing that the company’s dual engine—legacy software profi...
As AI server demand remains robust, one legacy tech giant stands out as a buy-after-pullback play. This piece weighs ...
Toyota strengthens its global cash-flow engine with hybrids and expanding markets, while Ford grapples with EV losses...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
This guide breaks down what to watch in Jackson Financial's 2025 earnings, with practical tips and real-world scenari...
As investors prepare for Personalis (PSNL) 2025 earnings, this guide breaks down what to watch, how to interpret the ...